Erin Schenk MD, PhD
Assistant Professor of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Denver, Colorado
Dr. Erin Schenk is an Assistant Professor of Medicine in the Division of Medical Oncology at the University of Colorado Anschutz Medical Campus. She specializes in thoracic oncology.
Dr. Schenk received her MD and PhD from the Mayo Clinic Medical Scientist Training Program in Rochester, Minnesota. Her thesis work focused on the adaptive immune response to cancer antigens. She completed her internal medicine residency and fellowship at Mayo Clinic with a continued focus in tumor immunology through the Clinician-Investigator Training Program. The Schenk Lab is part of the Thoracic Oncology Research Initiative at the University of Colorado and investigates the lung cancer tumor microenvironment as a contributor to lung cancer progression and treatment resistance.
Dr. Schenk received her MD and PhD from the Mayo Clinic Medical Scientist Training Program in Rochester, Minnesota. Her thesis work focused on the adaptive immune response to cancer antigens. She completed her internal medicine residency and fellowship at Mayo Clinic with a continued focus in tumor immunology through the Clinician-Investigator Training Program. The Schenk Lab is part of the Thoracic Oncology Research Initiative at the University of Colorado and investigates the lung cancer tumor microenvironment as a contributor to lung cancer progression and treatment resistance.
Recent Contributions to PracticeUpdate:
- Improving Tolerability of mXELIRI in mCRC: A Safety and Efficacy Comparison With FOLFIRI—A West Cancer Center Perspective
- Durvalumab as Late Stage Treatment of NSCLC: Relationship With EGFR, ALK and PD-L1 Positivity—A West Cancer Center Perspective
- Combining Checkpoint Inhibitors and VEGF Inhibitors for First-Line RCC: Early Data and Indications—A West Cancer Center Perspective
- On TRK for a New Target in Cancer Therapy
- Direct Detection of Early-Stage Cancers Using Circulating Tumor DNA
- Role of Microsatellite Instability in Solid Tumors: Clinical Implications
- Cancer Immunotherapy Through Checkpoint Inhibitors
- Epigenetic Signatures of Cigarette Smoking